These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 24970670)

  • 1. Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves.
    Schwietz T; Behjati S; Gafoor S; Seeger F; Doss M; Sievert H; Zeiher AM; Fichtlscherer S; Lehmann R
    EuroIntervention; 2015 Apr; 10(12):1468-73. PubMed ID: 24970670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
    Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
    Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
    Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
    Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The systemic inflammatory response syndrome predicts short-term outcome after transapical transcatheter aortic valve implantation.
    Rettig TC; Rigter S; Nijenhuis VJ; van Kuijk JP; ten Berg JM; Heijmen RH; van de Garde EM; Noordzij PG
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):283-7. PubMed ID: 25649701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transapical aortic valve implantation in patients with previous cardiac surgery.
    Papadopoulos N; Ilioska P; Fichtlscherer S; Lehmann R; Beiras Fernandez A; Moritz A; Doss M; Zierer A
    Ann Thorac Surg; 2014 Jan; 97(1):37-42. PubMed ID: 24075497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study.
    Stähli BE; Grünenfelder J; Jacobs S; Falk V; Landmesser U; Wischnewsky MB; Lüscher TF; Corti R; Maier W; Altwegg LA
    J Invasive Cardiol; 2012 Aug; 24(8):407-11. PubMed ID: 22865312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
    Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
    Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midterm outcomes after transcatheter aortic valve implantation.
    Lotfi S; Dohmen G; Götzenich A; Haushofer M; Spillner JW; Autschbach R; Hoffmann R
    Innovations (Phila); 2014; 9(5):343-7; discussion 348. PubMed ID: 25238419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation.
    Amabile N; Azmoun A; Ghostine S; Ramadan R; Haddouche Y; Raoux F; To NT; Troussier X; Nottin R; Caussin C
    Int J Cardiol; 2013 Sep; 168(1):151-6. PubMed ID: 23079085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study.
    Kahlert P; Al-Rashid F; Döttger P; Mori K; Plicht B; Wendt D; Bergmann L; Kottenberg E; Schlamann M; Mummel P; Holle D; Thielmann M; Jakob HG; Konorza T; Heusch G; Erbel R; Eggebrecht H
    Circulation; 2012 Sep; 126(10):1245-55. PubMed ID: 22899774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late changes in quality of life following transcatheter aortic valve implantation using the transfemoral and transapical approaches.
    Bona V; Khawaja MZ; Bapat V; Young C; Hancock J; Redwood S; Fusari M; Thomas M
    EuroIntervention; 2015 Jun; 11(2):221-9. PubMed ID: 24769484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation.
    Sinning JM; Scheer AC; Adenauer V; Ghanem A; Hammerstingl C; Schueler R; Müller C; Vasa-Nicotera M; Grube E; Nickenig G; Werner N
    Eur Heart J; 2012 Jun; 33(12):1459-68. PubMed ID: 22285582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes After Transapical and Transfemoral Transcatheter Aortic Valve Insertion: An Evolving Experience.
    Murashita T; Greason KL; Pochettino A; Sandhu GS; Nkomo VT; Bresnahan JF; Reeder GS; Holmes DR; Rihal CS; Mathew V
    Ann Thorac Surg; 2016 Jul; 102(1):56-61. PubMed ID: 27112646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
    Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfemoral versus transapical approach for transcatheter aortic valve implantation: hospital outcome and risk factor analysis.
    Ferrari E; Eeckhout E; Keller S; Muller O; Tozzi P; Berdajs D; von Segesser LK
    J Cardiothorac Surg; 2017 Sep; 12(1):78. PubMed ID: 28874169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Carotid Artery as a Preferred Alternative Access Route for Transcatheter Aortic Valve Replacement.
    Kirker EB; Hodson RW; Spinelli KJ; Korngold EC
    Ann Thorac Surg; 2017 Aug; 104(2):621-629. PubMed ID: 28274520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study.
    van der Boon RM; Marcheix B; Tchetche D; Chieffo A; Van Mieghem NM; Dumonteil N; Vahdat O; Maisano F; Serruys PW; Kappetein AP; Fajadet J; Colombo A; Carrié D; van Domburg RT; de Jaegere PP
    Ann Thorac Surg; 2014 Jan; 97(1):22-8. PubMed ID: 24263012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cost of innovation in treating aortic stenosis: transcatheter aortic valve implantation].
    Bartoli S; Saia F; Marrozzini C; Berti E; Guastaroba P; Fortuna D; Ciuca C; Moretti C; Marzocchi A; De Palma R
    G Ital Cardiol (Rome); 2012 Jan; 13(1):50-8. PubMed ID: 22322472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional left ventricular function after transapical vs. transfemoral transcatheter aortic valve implantation analysed by cardiac magnetic resonance feature tracking.
    Meyer CG; Frick M; Lotfi S; Altiok E; Koos R; Kirschfink A; Lehrke M; Autschbach R; Hoffmann R
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1168-76. PubMed ID: 24906997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.